Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmaceutical Product Development (PPD), a US-based contract research organisation, has opened a vaccine clinical research center in Taizhou, China, further strengthening its clinical research and development services in one of the country’s major regions for conducting vaccine studies. PPD has opened its first office in China in 2003.
Subscribe to our email newsletter
Through the center, PPD is expected to provide clinical monitoring services to global and local biopharmaceutical companies seeking to develop vaccines in China.
Additionally, the center will help biopharmaceutical companies address requirements for conducting vaccine clinical trials in the country.
Simon Britton, vice president of clinical development for Asia Pacific at PPD, said: “Our strong expertise in vaccine clinical research and large presence in China make us well positioned to help our clients ensure adherence to global standards while addressing unique requirements for monitoring vaccine studies.”